Examining how COVID-19 changed pulmonary procedures
The Impact of COVID-19 on Pulmonary Procedures: A Nationwide Survey
M.D. Anderson Cancer Center · NCT05022446
This study looks at how doctors who treat lung conditions changed their procedures and staffing during the COVID-19 pandemic to see what worked best.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05022446 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the adaptations made by pulmonary procedural programs across the United States in response to the COVID-19 pandemic. It aims to assess changes in procedural practices, ambulatory operations, and provider staffing among pulmonologists. Participants will complete a survey that takes approximately 5-10 minutes, providing valuable insights into how these programs adjusted during the crisis. The findings may guide future practices and research efforts in pulmonary medicine during pandemics.
Who should consider this trial
Good fit: Ideal candidates for this study are pulmonologists who are members of the American Association of Bronchology and Interventional Pulmonology or the American College of Chest Physicians.
Not a fit: Patients who are not pulmonologists or who do not belong to the specified professional organizations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the preparedness and response of pulmonary programs during future pandemics.
How similar studies have performed: While this study focuses on a specific adaptation to the COVID-19 pandemic, similar studies have shown success in assessing changes in medical practices during health crises.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP) * These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership Exclusion Criteria: None
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Bruce F Sabath, MD — M.D. Anderson Cancer Center
- Study coordinator: Jhankruti F Zaveri, MPH
- Email: jzaveri@mdanderson.org
- Phone: (713) 745-2645
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm